Abstracts tagged "diagnosis"

Abstract Number: 664 • 2015 ACR/ARHP Annual Meeting
Patient Reported Outcomes and Assessment of the Quality of Life in a Cohort of Patients Affected By Enteropathic Spondyloarthritis: Definitive Results of a Monocentric Prospective Observational Study at One Year
Chiara Avellini¹, Laura Bolognini², Alessia Farinelli¹, Monia Ciferri³, Greta Gambacorta³, Devis Benfaremo³, Serena Cedraro³, Matteo Rossini³, William Capeci³, Lucia Manfredi³, Laura Postacchini³, Giammarco Fava², Piergiorgio Mosca², Giovanni Pomponio³, Michele Maria Luchetti³ and Armando Gabrielli³, ¹Scienze Cliniche e Molecolari, Clinica Medica, Università Politecnica delle Marche, Ancona, Italy, ²Gastroenterologia, Azienda "Umberto I-G.M.Lancisi-G.Salesi", Ancona, Italy, ³Clinica Medica, Università Politecnica delle Marche, Ancona, Italy
Background/Purpose: Enteropathic spondyloarthritis (ES) are included in the group of the spondyloarthritis (SpA). Because articular involvement is the most frequent extra-intestinal manifestation in patients with…
Abstract Number: 683 • 2015 ACR/ARHP Annual Meeting
Referral Strategies for the Early Diagnosis of Axial Spondyloarthritis- a Systematic Review
Abhijeet Danve¹ and Atul A. Deodhar², ¹Internal Medicine - Rheumatology, University of Nebraska Medical Center, Omaha, NE, ²Division of Arthritis & Rheumatic Diseases, Oregon Health & Science University, Portland, OR
Background/Purpose: Axial Spondyloarthritis (axSpA) is often misdiagnosed or diagnosed late (average delay 8 to 11 years) since low back pain (LBP) is very common in…
Abstract Number: 914 • 2015 ACR/ARHP Annual Meeting
When Fibromyalgia Criteria Misclassify
Frederick Wolfe¹ and Winfried Häuser², ¹National Data Bank, Wichita, KS, ²Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, Munich, Germany
Background/Purpose : The 2010 American College of Rheumatology (ACR) preliminary criteria for the diagnosis of fibromyalgia (FM2010) and its extension for clinical research by patient self-report…
Abstract Number: 1241 • 2015 ACR/ARHP Annual Meeting
Identification and Validation of Diagnostic and Activity Urinary Metabolomic Biomarkers in Immune-Mediated Inflammatory Diseases
Arnald Alonso¹, Jesús Tornero², Antonio Fernandez-Nebro³, Juan D. Cañete⁴, Eugeni Domènech⁵, Javier P. Gisbert⁶, Carlos Ferrándiz⁵, Eduardo Fonseca⁷, Valle García⁸, Francisco Blanco⁷, Jesus Rodriguez⁹, Jordi Gratacós¹⁰, Patricia E. Carreira¹¹, Antonio Julià¹, Raül Tortosa¹, Maria López-Lasanta¹², Xavier Correig¹³ and Sara Marsal¹, ¹Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain, ²Rheumatology Department, Hospital Universitario Guadalajara, Guadalajara, Spain, ³Rheumatology, Hospital Universitario Carlos Haya, Malaga, Spain, ⁴Unitat d’Artritis, Servei de Reumatologia, Hospital Clínic de Barcelona and Institut d’Investigacions Biomèdiques August Pí i Sunyer, Barcelona, Spain, ⁵Hospital Universitari Germans Trias I Pujol, Badalona, Spain, ⁶Hospital Universitario de la Princesa, Madrid, Spain, ⁷Complejo Hospitalario Juan Canalejo, A Coruña, Spain, ⁸Hospital Universitario Reina Sofía, Córdoba, Spain, ⁹Rheumatology, Hospital Universitari de Bellvitge, Barcelona, Spain, ¹⁰Hospital Parc Taulí, Sabadell, Spain, ¹¹Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, ¹²Vall d'Hebron Hospital Research Institute, Barcelona, Spain, ¹³CIBERDEM, Metabolomics Platform, Reus, Spain
Background/Purpose: The recent advances in metabolomics have allowed the study of the regulatory processes linked to metabolism. The comprehensive analysis of the metabolome in biological samples…
Abstract Number: 1157 • 2014 ACR/ARHP Annual Meeting
Delay in Diagnosis from Onset of Symptoms By More Than One Year in 31% of Patients with Different Rheumatic Diseases in Australia
Isabel Castrejón¹, Kathryn A. Gibson² and Theodore Pincus¹, ¹Rheumatology, Rush University Medical Center, Chicago, IL, ²Liverpool Hospital, Liverpool, Australia
Background/Purpose: Early treatment is regarded as critical for optimal clinical outcomes in patients with inflammatory rheumatic diseases. However, delayed diagnosis is recognized in many rheumatic…
Abstract Number: 883 • 2014 ACR/ARHP Annual Meeting
Accuracy of High Resolution MRI of Scalp Arteries for the Diagnosis of Giant Cell Arteritis: Results of a Prospective Study
Maxime Rhéaume¹, Ryan Rebello², Christian Pagnoux³, Simon Carette³, Marie Clements-Baker⁴, Violette Cohen-Hallaleh², David Doucette-Preville², B. Stanley Jackson⁵, Sam Salama⁶, George Ioannidis⁷ and Nader A. Khalidi¹, ¹Division of Rheumatology, St. Joseph’s Hospital, McMaster University, Hamilton, ON, Canada, ²Department of Radiology, St. Joseph’s Hospital, McMaster University, Hamilton, ON, Canada, ³Division of Rheumatology, University of Toronto, Toronto, ON, Canada, ⁴Rheumatology, Queens University, Kingston, ON, Canada, ⁵Department of Surgery, St. Joseph’s Hospital, McMaster University, Hamilton, ON, Canada, ⁶Department of Pathology, St. Joseph’s Hospital, McMaster University, Hamilton, ON, Canada, ⁷St Joseph's Healthcare Hamilton, Hamilton, ON, Canada
Background/Purpose: Temporal artery biopsy (TAB) remains the gold standard for the diagnosis of giant cell arteritis (GCA). It is invasive and its sensitivity is limited…
Abstract Number: 454 • 2014 ACR/ARHP Annual Meeting
The Specificity of Anti-Carbamylated Protein Antibodies for Rheumatoid Arthritis in a Setting of Early Arthritis
Jing Shi, H.W. van Steenbergen, J. a. B. van Nies, E.W.Nivine Levarht, Annette H. M. van der Helm- van Mil, Tom W. J. Huizinga, René E.M. Toes and Leendert A. Trouw, Rheumatology, Leiden University Medical Center, Leiden, Netherlands
Background/Purpose Anti-carbamylated protein (anti-CarP) antibodies have been described in rheumatoid arthritis (RA) and arthralgia patients [1;2] and occur in subsets of the anti-CCP2 positive and…
Abstract Number: 431 • 2014 ACR/ARHP Annual Meeting
Joint Dermal Temperature Specifically Identifies the Individual RA Patient Most Likely to Develop Radiographic Change on Sharp Score; An Exam in Less Than a Minute Can Predict Who Specifically Needs Biologic Therapy
Maria Greenwald¹, Joann Ball² and Harold Paulus³, ¹Desert Medical Advances, PALM DESERT, CA, ²rheumatology, Desert Medical Advaces, Palm Desert, CA, ³Rheumatology, UCLA, Los Angeles, CA
Background/Purpose: Joint dermal temperature (temp) measured in less than a minute can identify specifically the individual RA patient most likely to develop radiographic change on…
Abstract Number: 407 • 2014 ACR/ARHP Annual Meeting
Serum 14-3-3η Protein Supplements Traditional Rheumatoid Arthritis Biomarkers
Olga Zhukov¹, Jonnielyn Rivera¹, Charles M. Rowland², Joanna M. Popov¹ and Stanley J. Naides³, ¹Immunology, Quest Diagnostics Nichols Institute, San Juan Capistrano, CA, ²Bioinformatics, Celera, Alameda, CA, ³Immunology, Quest Diagnostics, San Juan Capistrano, CA
Background/Purpose: The 14-3-3 family of chaperonin proteins consists of 7 isomers. The tissue distribution of the 14-3-3η (eta) isoform is limited to synovial tissue and…
Abstract Number: 284 • 2014 ACR/ARHP Annual Meeting
Single Hub and Access Point for Paediatric Rheumatology in Europe (SHARE)– Evidence Based Recommendations for Diagnosis and Treatment of Juvenile Idiopathic Arthritis
S.J. Vastert¹, Victor Boom², Jordi Anton³, Tamás Constantin⁴, Pavla Dolezalova⁵, Gerd Horneff⁶, Pekka Lahdenne⁷, Bo Magnusson⁸, Kirsten Minden⁹, K. Nistala¹⁰, Pierre Quartier¹¹, Ingrida Rumba-Rozenfelde¹², Nicolino Ruperto¹³, Vanessa Remy Piccolo¹⁴, Ricardo A. G. Russo¹⁵, Yosef Uziel¹⁶, Carine Wouters¹⁷, Alberto Martini¹⁸, Angelo Ravelli¹⁹, Helen Foster²⁰ and Nico Wulffraat²¹, ¹Pediatric Rheumatology, University Medical Center Utrecht, Utrecht, Netherlands, ²Paediatric Rheumatology, University Medical Center Utrecht, Utrecht, Netherlands, ³Pediatric Rheumatology Unit. Hospital Sant Joan de Déu. Universitat de Barcelona, Barcelona, Spain, ⁴Pediatric Rheumatology, University Childrens Hospital, Budapest, Hungary, ⁵Paediatric Rheumatiology unit, 1st Faculty of Medicine, General University Hospital, Prague, Czech Republic, ⁶Asklepios Klinik Sankt Augustin, Sankt Augustin, Germany, ⁷Paediatrics, Helsinki University Central Hospital, Helsinki, Finland, ⁸Pediatric Rheumatology, Astrid Lindgren Children's Hospital, Stockholm, Sweden, ⁹Epidemiology unit, German Rheumatism Research Center, Berlin, Germany, ¹⁰Centre for Rheumatology, University College London, London, United Kingdom, ¹¹Pediatric Rheumatology, IMAGINE Institute, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Université Paris-Descartes, Paris, France, ¹²University of Latvia, Riga, Latvia, ¹³Pediatria II,, Istituto Giannina Gaslini, Genoa, Italy, ¹⁴Pediatric Rheumatology, Hopital Necker Enfants Malades, Paris, France, ¹⁵Immunology & Rheumatology, Hospital de Pediatria Garrahan, Buenos Aires, Argentina, ¹⁶Tel-Aviv University, Sackler School of Medicine, Tel-Aviv, Israel, ¹⁷University of Leuven, Laboratory of Pediatric Immunology, University Hospital Leuven, Leuven, Belgium, ¹⁸Istituto Giannina Gaslini, Genova, Italy, ¹⁹University of Genova, Genova, Italy, ²⁰Newcastle University, Newcastle, United Kingdom, ²¹Paediatric Immunology and Rheumatology, University Medical Center Utrecht, Utrecht, Netherlands
Background/Purpose Juvenile Idiopathic Arthritis (JIA) is one of the most common chronic pediatric rheumatic diseases (PRD). As is the case for most PRD's, evidence-based guidelines…
Abstract Number: 256 • 2014 ACR/ARHP Annual Meeting
Characteristics of Pain in Fabry Disease
Olivier Lidove¹, Esther Noel², Eric Hachulla³, Francis Gaches⁴, Claire Douillard⁵, Bernadette Darne⁶, Kim Heang Ly⁷, Christian Lavigne⁸, Agathe Masseau⁹, Laurent Aaron¹⁰, Boris Bienvenu¹¹, Thierry Zenone¹², Philippe Vitielli⁶, Vanessa Leguy-Seguin¹³ and Jean Marc Ziza¹⁴, ¹Médecine interne, Hôpital Croix-Saint-Simon, PARIS, France, ²CHU de Strasbourg - Hopital Civil, Strasbourg, France, ³Faculté de Médecine Henri Warembourg, Université Lille Nord de France, Lille, France, ⁴Hopital Joseph Ducuing, Toulouse, France, ⁵CHU Lille, Lille, France, ⁶Monitoring Force, Maisons-Laffitte, France, ⁷CHU Dupuytren, Limoges, Limoges, France, ⁸CHU d'Angers, Angers, France, ⁹Internal Medicine Department, Nantes University Hospital, Nantes, France, ¹⁰Internal Medicine, Hôpital Jacques Coeur, Bourges, Bourges, France, ¹¹Médecine interne, CHU Côte de Nacre, CAEN, France, ¹²CH de Valence, Valence, France, ¹³CHU Dijon, Dijon, France, ¹⁴Hopital Croix-Saint-Simon, Paris Cedex 20, France
Background/Purpose Fabry disease (FD) is an X-linked disorder caused by a deficiency of lysosomal alpha-galactosidase A resulting in accumulation of glycosphingolipids. Clinical manifestations include a…
Abstract Number: 202 • 2014 ACR/ARHP Annual Meeting
Is Schuss View Alone Enough for the Diagnosis of Femorotibial Osteoarthritis ? the Khoala Cohort Study
Christian Roux¹, Bernard Mazieres², Evelyne Verrouil², Anne-Christine Rat,³, Patrice Fardellone⁴, Bruno Fautrel⁵, Jacques Pouchot⁶, Alain Saraux⁷, Francis Guillemin⁸, Liana Euller Ziegler⁹ and Joel Coste¹⁰, ¹Rhumatologie, Hopital Archet 1 - Université Nice Sophia Antipolis, Nice, France, ²CHU Toulouse, Toulouse, France, ³Université de Lorraine, Université Paris Descartes, Apemac, EA 4360, Nancy, France, ⁴Service de Rhumatologie, Hôpital Nord, C.H.U. d'Amiens, Amiens, France, ⁵CHU - Hôpital Pitié-Salpêtrière, Paris, France, ⁶Medecine Interne, Hopital Louis Mourier, Colombes, FRANCE, France, ⁷Rheumatology, CHU de la Cavale Blanche and Université Bretagne occidentale, Brest Cedex, France, ⁸INSERM, Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC) CIE6, Nancy, France, ⁹151 rte de St Antoine de Gines, CHU de Nice -Université Nice Sophia Antipolis, Nice, France, ¹⁰CHU Hotel Dieu, Paris, France
Background/Purpose: Associating an anteroposterior (AP) extended-knee X-ray with a semiflexed AP or posteroanterior (PA) view is considered the gold standard for radiologically diagnosing tibiofemoral osteoarthritis…
Abstract Number: 2774 • 2014 ACR/ARHP Annual Meeting
Why Leg Ulcers Do Not Heal? a Prospective Study Showing High Proportion of Small Vessel Vasculitis
Vinod Ravindran¹, Sunil Rajendran² and Ranjish Vijayan², ¹National Hospital, Kozhikode, Kerala, India, ²PVS Hospital, Kozhikode, India
Background/Purpose: Non healing cutaneous ulcers of lower limbs can have several different aetiologies [1]. It is likely that the patients with such ulcers would be…
Abstract Number: 2624 • 2014 ACR/ARHP Annual Meeting
Impact of Provider Specialty on the Diagnosis and Management of Systemic Lupus Erythematosus in the American Indian/Alaska Native Population
John McDougall Jr.¹, Charles G. Helmick², S. Sam Lim³, Caroline Gordon⁴ and Elizabeth Ferucci⁵, ¹Department of Internal Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, ²National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, ³Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, ⁴Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, ⁵Alaska Native Medical Center, Anchorage, AK
Background/Purpose Systemic lupus erythematosus (SLE) is a complex disease that is traditionally diagnosed and managed by specialists, typically rheumatologists. Higher SLE prevalence in racial/ethnic minorities…
Abstract Number: 2279 • 2014 ACR/ARHP Annual Meeting
Evidence Based Recommendations for Diagnosis and Management of Tumor Necrosis Factor Receptor-1 Associated Periodic Syndrome (TRAPS)
Nienke ter Haar¹, Paul Brogan², Gilles Grateau³, Jordi Anton⁴, Karyl Barron⁵, Luca Cantarini⁶, Joost Frenkel⁷, Caroline Galeotti⁸, Veronique Hentgen⁹, Michael Hofer¹⁰, Tilmann Kallinich¹¹, Isabelle Kone-Paut¹², Jasmin Kuemmerle-Deschner¹³, Huri Ozdogan¹⁴, Seza Ozen¹⁵, Ricardo Russo¹⁶, Anna Simon¹⁷, Yosef Uziel¹⁸, Carine Wouters¹⁹, Brian Feldman²⁰, Bas Vastert⁷, Nico Wulffraat²¹, Helen Lachmann²² and Marco Gattorno²³, ¹Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands, ²Rheumatology Unit, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom, ³Service De Médecine Interne, Hopital Tenon, Paris, France, ⁴Pediatric Rheumatology Unit. Hospital Sant Joan de Déu. Universitat de Barcelona, Barcelona, Spain, ⁵NIH, Bethesda, MD, ⁶University of Siena, Siena, Italy, ⁷University Medical Center Utrecht, Utrecht, Netherlands, ⁸Bicêtre Hospital, University of Paris SUD, Paris, France, ⁹Versailles Hospital, Le Chesnay Cedex, France, ¹⁰Centre Multisite Romand de Rhumatologie Pediatrique, Lausanne, Switzerland, ¹¹Charite, University Medicine Berlin, Berlin, Germany, ¹²Department of Pediatric Rheumatology, Reference Centre for Autoinflammatory Disorders CEREMAI, Bicêtre Hospital, University of Paris SUD, Paris, France, ¹³Pediatrics, University Hospital Tuebingen, Tuebingen, Germany, ¹⁴Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, ¹⁵Deptartment. of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey, ¹⁶Immunology & Rheumatology, Hospital De Pediatria, Buenos Aires, Argentina, ¹⁷Radboudumc, Nijmegen, Netherlands, ¹⁸Tel-Aviv University, Sackler School of Medicine, Tel-Aviv, Israel, ¹⁹University of Leuven, Laboratory of Pediatric Immunology, University Hospital Leuven, Leuven, Belgium, ²⁰Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ²¹Pediatric rheumatology, Wilhelmina Children's Hospital/ UMC Utrecht, Utrecht, Netherlands, ²²UK National Amyloidosis Centre, University College London Medical School, London, United Kingdom, ²³Istituto Giannina Gaslini, Genova, Italy
Background/Purpose Tumor necrosis factor receptor-1 associated periodic syndrome (TRAPS) is a rare hereditary autoinflammatory syndrome that can lead to significant morbidity. Evidence-based guidelines are lacking…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].